Literature DB >> 10458759

SSTR2A is the dominant somatostatin receptor subtype expressed by inflammatory cells, is widely expressed and directly regulates T cell IFN-gamma release.

D E Elliott1, J Li, A M Blum, A Metwali, Y C Patel, J V Weinstock.   

Abstract

Macrophages secrete the immunoregulatory peptide somatostatin (SOM) that inhibits IFN-gamma release by splenocytes and granuloma cells of schistosome-infected mice. In this report we demonstrate that granuloma cells express mRNA for the SOM receptor SSTR2 but not the other four SSTR subtypes. Blocking SSTR2 activity with anti-SSTR2 antiserum prevents SOM inhibition of T cell IFN-gamma production. This demonstrates that SOM regulates T cell function via SSTR2. Two isoforms of SSTR2 exist due to alternative RNA splicing. We developed sensitive and specific competitive PCR assays to quantify total SSTR2, SSTR2A and SSTR2B mRNA levels. The SSTR2A isoform accounts for 99% of inflammatory cell SSTR2 mRNA and does not appear to be regulated at the transcripitonal level. B cells and macrophage cell lines also express SSTR2 mRNA which raises the possibility that SOM influences T cell IFN-gamma release by regulating accessory cell function. We show that SOM acts directly on T cells to inhibit TCR-stimulated IFN-gamma release. Thus, SOM may directly regulate T cell IFN-gamma release at inflammatory sites.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458759     DOI: 10.1002/(SICI)1521-4141(199908)29:08<2454::AID-IMMU2454>3.0.CO;2-H

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  29 in total

1.  Galpha(14) links a variety of G(i)- and G(s)-coupled receptors to the stimulation of phospholipase C.

Authors:  M K Ho; L Y Yung; J S Chan; J H Chan; C S Wong; Y H Wong
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 2.  Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions.

Authors:  Erika Pintér; Gábor Pozsgai; Zsófia Hajna; Zsuzsanna Helyes; János Szolcsányi
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

Review 3.  Non-invasive Reporter Gene Imaging of Cell Therapies, including T Cells and Stem Cells.

Authors:  Candice Ashmore-Harris; Madeleine Iafrate; Adeel Saleem; Gilbert O Fruhwirth
Journal:  Mol Ther       Date:  2020-03-20       Impact factor: 11.454

Review 4.  Advances in the therapy of gastroenteropancreatic-neuroendocrine tumours (GEP-NETs).

Authors:  Enrique Grande; Juan José Díez; Vanessa Pachón; Alfredo Carrato
Journal:  Clin Transl Oncol       Date:  2010-07       Impact factor: 3.405

5.  False-positive In-111 DTPA octreotide scintigraphy in bilateral tibial insufficiency fracture.

Authors:  Reza Vali; Marilyn Ranson; Elizabeth Harvey; Amer Shammas
Journal:  Pediatr Radiol       Date:  2014-06-06

6.  Treatment of Helicobacter gastritis with IL-4 requires somatostatin.

Authors:  Yana Zavros; Sivaprakash Rathinavelu; John Y Kao; Andrea Todisco; John Del Valle; Joel V Weinstock; Malcolm J Low; Juanita L Merchant
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-10       Impact factor: 11.205

7.  Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice.

Authors:  Zsuzsanna Helyes; Erika Pintér; Katalin Sándor; Krisztián Elekes; Agnes Bánvölgyi; Dániel Keszthelyi; Eva Szoke; Dániel M Tóth; Zoltán Sándor; László Kereskai; Gábor Pozsgai; Jeremy P Allen; Piers C Emson; Adrienn Markovics; János Szolcsányi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-21       Impact factor: 11.205

8.  Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor.

Authors:  Sergei Spitsin; Florin Tuluc; John Meshki; Jian Ping Lai; Richard Tustin Iii; Steven D Douglas
Journal:  Neuroimmunomodulation       Date:  2013-07-05       Impact factor: 2.492

9.  The somatostatin analog SOM230 (pasireotide) ameliorates injury of the intestinal mucosa and increases survival after total-body irradiation by inhibiting exocrine pancreatic secretion.

Authors:  Qiang Fu; Maaike Berbée; Marjan Boerma; Junru Wang; Herbert A Schmid; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2009-06       Impact factor: 2.841

10.  Effects of somatostatin and octreotide on cytokine and chemokine production by lipopolysaccharide-activated peripheral blood mononuclear cells.

Authors:  F ter Veld; B Rose; R Mussmann; S Martin; C Herder; K Kempf
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.